-60%? Ups!
WKN: 728853
Authorized Outstanding
Date Shares Source Date Shares Source
n/a 11/13/2003 19,027,779
isht.comdirect.de/charts/...ors=0x000000&sSym=NWBT.NAP&hcmask=
Deutschland:
isht.comdirect.de/charts/...lors=0x000000&sSym=NBY.BER&hcmask=
Börse NASDAQ OTC BBS
Aktuell 0,02 USD
Zeit 23.04.04 21:57
Diff. Vortag -60,78 %
Tages-Vol. 24.759,50
Geh. Stück 930.000
Geld 0,016
Brief 0,025
Zeit 23.04.04 21:55
Spread 36%
Geld Stk. --
Brief Stk. --
Schluss
Vortag 0,051
Eröffnung 0,04
Hoch 0,055
Tief 0,015
52W Hoch 0,42
52W Tief 0,04
NWBTE NORTHWEST BIOTHERAPEUTICS
--------------------------------------------------
NWBTE: Volume Spike; 398% > 20-adsv, Stock -60.78%
FRIDAY , APRIL 23, 2004 03:39 PM
This is the 1st VOLUME alert for NWBTE in the past 7 calendar days.
Trading for Northwest BioTherapeutics (OTCBB: NWBTE) has been heavier than usual in today's session. By 15:40 ET, the stock had already traded 670,000 shares via 46 trades. The cumulative volume is 397.60% above its 20-day average of 134,646. Normally the stock experiences around 14 individual trades per session.
So far, today's volume surge has caused a net decline in NWBTE's stock price. At the time of this alert, the stock was trading at $0.020, down $-0.031 (-60.78%).
One year ago, the Company's shares closed at $0.220. The price has declined more than 90 percent since then.
Over the last 10 trading session NWBTE has traded in a range between $0.040 and $0.140 and is currently trading 95.24% below its 52-week high of $0.420 set on July 15, 2003 and 50.00% below its 52-week low of $0.040 from April 21, 2004.
In the previous 3 sessions, NWBTE trading has displayed a mixed trend. Closing results have been as follows:
April 22, 2004 --- closed at $0.051 up $0.001 (+2.00%) on 15,200 shares
April 21, 2004 --- closed at $0.050 up $0.010 (+25.00%) on 218,100 shares
April 20, 2004 --- closed at $0.040 down $0.030 (-42.86%) on 866,200 shares
The Company has not released news in the past 30 days
NORTHWEST BIOTHERAPEUTICS
A biotechnology company focused on discovering, developing and commercializing immunotherapy products that safely generate and enhance immune system responses to effectively treat cancer.
WKN: 728853
Authorized Outstanding
Date Shares Source Date Shares Source
n/a 11/13/2003 19,027,779
isht.comdirect.de/charts/...ors=0x000000&sSym=NWBT.NAP&hcmask=
Deutschland:
isht.comdirect.de/charts/...lors=0x000000&sSym=NBY.BER&hcmask=
Börse NASDAQ OTC BBS
Aktuell 0,02 USD
Zeit 23.04.04 21:57
Diff. Vortag -60,78 %
Tages-Vol. 24.759,50
Geh. Stück 930.000
Geld 0,016
Brief 0,025
Zeit 23.04.04 21:55
Spread 36%
Geld Stk. --
Brief Stk. --
Schluss
Vortag 0,051
Eröffnung 0,04
Hoch 0,055
Tief 0,015
52W Hoch 0,42
52W Tief 0,04
NWBTE NORTHWEST BIOTHERAPEUTICS
--------------------------------------------------
NWBTE: Volume Spike; 398% > 20-adsv, Stock -60.78%
FRIDAY , APRIL 23, 2004 03:39 PM
This is the 1st VOLUME alert for NWBTE in the past 7 calendar days.
Trading for Northwest BioTherapeutics (OTCBB: NWBTE) has been heavier than usual in today's session. By 15:40 ET, the stock had already traded 670,000 shares via 46 trades. The cumulative volume is 397.60% above its 20-day average of 134,646. Normally the stock experiences around 14 individual trades per session.
So far, today's volume surge has caused a net decline in NWBTE's stock price. At the time of this alert, the stock was trading at $0.020, down $-0.031 (-60.78%).
One year ago, the Company's shares closed at $0.220. The price has declined more than 90 percent since then.
Over the last 10 trading session NWBTE has traded in a range between $0.040 and $0.140 and is currently trading 95.24% below its 52-week high of $0.420 set on July 15, 2003 and 50.00% below its 52-week low of $0.040 from April 21, 2004.
In the previous 3 sessions, NWBTE trading has displayed a mixed trend. Closing results have been as follows:
April 22, 2004 --- closed at $0.051 up $0.001 (+2.00%) on 15,200 shares
April 21, 2004 --- closed at $0.050 up $0.010 (+25.00%) on 218,100 shares
April 20, 2004 --- closed at $0.040 down $0.030 (-42.86%) on 866,200 shares
The Company has not released news in the past 30 days
NORTHWEST BIOTHERAPEUTICS
A biotechnology company focused on discovering, developing and commercializing immunotherapy products that safely generate and enhance immune system responses to effectively treat cancer.
